Acorai, a Swedish medical device start-up, begins global clinical trial with first patient enrolled in London. Their breakthrough heart monitor aims for FDA and CE-marking approval in 2024, offering improved heart failure management for 64
Zedsen is renowned for its non-invasive sensing technology applied to early breast cancer detection. With its world class team of scientists and engineers, Zedsen is developing a product to revolutionise the clinical pathway in cancer care.
apoQlar, a pioneering healthtech company, has successfully secured a funding round led by venture capital firm YZR Capital, specializing in health tech investments. This significant investment validates the potential of apoQlar's AR platfor
Tagworks Pharmaceuticals BV ("Tagworks"), the pioneer of Click-to-Release chemistry designed to deliver more effective and safer systemic therapies, today announced a $65 million Series A financing led by Ysios Capital and Gilde Healthcare